Growth Metrics

Mesoblast (MESO) Non-Current Deffered Revenue (2018 - 2025)

Mesoblast recorded quarterly Non-Current Deffered Revenue of $2.5 million in Q4 2025, little changed quarter-over-quarter from $2.5 million in Q2 2025, and little changed year-over-year from $2.5 million in Q4 2024.

Mesoblast's Non-Current Deffered Revenue history runs 8 years deep, the most recent figure standing at $2.5 million for Q4 2025.

  • In Q4 2025, Non-Current Deffered Revenue changed 0.0% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (changed 0.0% YoY), while the FY2025 annual figure was $2.5 million, changed 0.0% from the prior year.
  • Non-Current Deffered Revenue came in at $2.5 million for Q4 2025 at Mesoblast, roughly flat from $2.5 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $2.5 million in Q1 2021 to a low of $2.5 million in Q1 2021.
  • A 5-year average of $2.5 million and a median of $2.5 million in 2021 frame the typical range for Non-Current Deffered Revenue.
  • On a YoY basis, Non-Current Deffered Revenue climbed as much as 0.0% in 2021 and fell as far as 0.0% in 2021.
  • Mesoblast's Non-Current Deffered Revenue stood at $2.5 million in 2021, then changed by 0.0% to $2.5 million in 2022, then changed by 0.0% to $2.5 million in 2023, then changed by 0.0% to $2.5 million in 2024, then changed by 0.0% to $2.5 million in 2025.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $2.5 million, $2.5 million, and $2.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 225.10 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -
10 Mesoblast 23.40 Bn 23.27 Bn - 2.50 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 2.50 Mn
Jun 30, 2025 2.50 Mn
Dec 31, 2024 2.50 Mn
Jun 30, 2024 2.50 Mn
Dec 31, 2023 2.50 Mn
Jun 30, 2023 2.50 Mn
Mar 31, 2023 2.50 Mn
Dec 31, 2022 2.50 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2022 2.50 Mn
Mar 31, 2022 2.50 Mn
Dec 31, 2021 2.50 Mn
Sep 30, 2021 2.50 Mn
Jun 30, 2021 2.50 Mn
Mar 31, 2021 2.50 Mn
Dec 31, 2020 2.50 Mn
Sep 30, 2020 2.50 Mn
Jun 30, 2020 2.50 Mn
Mar 31, 2020 2.50 Mn
Dec 31, 2019 10.00 Mn
Sep 30, 2019 10.00 Mn
Jun 30, 2019 10.00 Mn
Mar 31, 2019 10.00 Mn
Dec 31, 2018 10.00 Mn
Sep 30, 2018 10.00 Mn